Correlation of Clinical and Pathological Parameters with the Diversity and Genetic Evolution of Breast Cancer in Senegalese Women
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2014, Vol 4, Issue 14
Abstract
Aims: The purpose of this study was to assess the hypothesis that genetic diversity of breast cancer is related to clinical and pathological tumors characteristics. Study Design: Representative sequences of mitochondrial Cytochrome b gene of cancerous tissues were analyzed to determinate diversity and genetic evolution of breast tumors in Senegalese women. Place and Duration of Study: Department of biology Animal (University Cheikh Anta Diop), laboratory of molecular biology (IRD-CBGP), 2011-2013. Methodology: Genetic diversity of breast tumors in 57 Senegalese patients was estimated by analyzing sequences of the Cytochrome b mitochondrial coding gene. The Cytochrome b sequences from cancerous tissues were aligned using BioEdit version 7.0.8. Number of polymorphic sites, parsimony informative sites, the rate of transitions/transversions and the nucleotide frequency were calculated using MEGA 5.05. Genetic distance (d) was calculated with MEGA 5 using the Kimura 2-parameter (K2P) model. The index of genetic differentiation (Fst) used to describe the distribution of the genetic diversity between sub-groups was calculated with the software DnaSP version 10.5.01. The significance level (P-value) was 0.05. Results: Analyses have revealed a high score of haplotype (Hd=0.991+/-0.008) and nucleotide diversity (Pi=0.15650+/-0.01326). Statistical correlations have shown a positive association between the risk factors (age of the patients, appearance of the first menstruation beyond 12 years, number of gestation) and nucleotide diversity of tumors (P<0.0001). Statistical analyses based on t-test showed a positive association between age, date of onset of the first menstruation and nucleotide diversity (Pi), between healthy and cancerous tissues for each patient (P<0.0001). Conclusion: Our results have shown an important genetic diversity in breast tumors. A strong genetic differentiation was noted depending on the number of gestations.
Authors and Affiliations
F. Mbaye, A. Dem, M. Fall, E. S. Mbaye, G. Diop, R. Ndiaye, M. S. Niang
Keywords
Related Articles
- EP ID EP349169
- DOI 10.9734/BJMMR/2014/6859
- Views 72
- Downloads 0
Evaluation of the Knowledge, Attitude and Practice of the Use of Insecticide- Treated Nets (ITNs) in Aba, Nigeria
Background: Over the past decade, significant gains have been made in the implementation of malaria preventive measures in sub-Saharan Africa, including the distribution of insecticide treated nets (ITNs). These have bee...
A Novel Approach for Innovative Pharmaceutical, Nutraceutical and Biocosmeceutical Products: Different Types of Combination Products and Co-activation of Natural Synergistically Acting Target-Receptors (CanSATs)
Traditionally, the main model of the pharmaceutical industry for developing new drugs has been based on monotherapies, new molecular entities (NMEs), and their underlying one-target-one-disease dogma. It is no surprise t...
Ovarian Cancer Symptom Awareness and Its Response among Female Health Workers
Objectives: To determine the level of awareness of ovarian cancer symptoms and help-seeking responses of female health workers. Methods: Four hundred and fifty seven female health workers were randomly selected and made...
Ease of Intubation with the McGRATH® MAC, C-MAC® or Macintosh Laryngoscopes by Novice Operators in Simulated Difficult Airways – A Manikin Study
A variety of video laryngoscopes have been introduced to facilitate endotracheal intubations as failed intubations can result in morbidity and mortality. We aimed to compare the use of the conventional Macintosh laryngos...
Coronary Heart Disease and Biomarkers and Its Clinical Application
Cardiovascular disease is a major health concern globally. Genetic testing is an attractive tool for cardiovascular disease prediction because it is a low-cost, high-fidelity technology with multiplex capability. Develop...